Detalles de la búsqueda
1.
Ultra rapid lispro (Lyumjev®) shortens time to recovery from hyperglycaemia compared to Humalog® in individuals with type 1 diabetes on continuous subcutaneous insulin infusion.
Diabetes Obes Metab
; 26(1): 215-223, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37814517
2.
Safety, tolerability, pharmacodynamics and pharmacokinetics following once-daily doses of BI 187004, an inhibitor of 11 beta-hydroxysteroid dehydrogenase-1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesity.
Diabetes Obes Metab
; 25(3): 832-843, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36478142
3.
Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon-like peptide-1 receptor agonist BI 456906.
Diabetes Obes Metab
; 25(4): 1011-1023, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36527386
4.
Pharmacokinetic and pharmacodynamic bioequivalence of Gan & Lee insulin analogues aspart (rapilin®), lispro (prandilin®) and glargine (basalin®) with EU- und US-sourced reference insulins.
Diabetes Obes Metab
; 25(12): 3817-3825, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37735841
5.
Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes.
Diabetes Obes Metab
; 25(5): 1351-1360, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36692230
6.
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin-R with the US-licensed Humulin® R formulation in healthy subjects: Results from the RHINE-1 (Recombinant Human INsulin Equivalence-1) study.
Diabetes Obes Metab
; 24(4): 713-721, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34981621
7.
Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double-blind meal test early-phase study.
Diabetes Obes Metab
; 24(2): 196-203, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34595812
8.
Acute effects of linagliptin on intact and total glucagon-like peptide-1 and gastric inhibitory polypeptide levels in insulin-dependent type 2 diabetes patients with and without moderate renal impairment.
Diabetes Obes Metab
; 24(5): 806-815, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34984794
9.
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin 70/30 with US-licensed HUMULIN® 70/30 formulation in healthy subjects: Results from the RHINE-3 (Recombinant Human INsulin Equivalence-3) study.
Diabetes Obes Metab
; 24(9): 1819-1828, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35589611
10.
Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial.
Br J Clin Pharmacol
; 87(5): 2303-2320, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33125753
11.
Better glycaemic control with BioChaperone glargine lispro co-formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetes.
Diabetes Obes Metab
; 21(7): 1570-1575, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30828929
12.
Sequential Treatment Escalation with Dapagliflozin and Saxagliptin Improves Beta Cell Function in Type 2 Diabetic Patients on Previous Metformin Treatment: An Exploratory Mechanistic Study.
Horm Metab Res
; 50(5): 403-407, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29727906
13.
Oral insulin: A history of ambition, failure and data torturing.
Diabetes Obes Metab
; 25(4): 940-942, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36692379
14.
Injecting without pressing a button: An exploratory study of a shield-triggered injection mechanism.
Diabetes Obes Metab
; 20(5): 1140-1147, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29369493
15.
Effects on α- and ß-cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic study.
Diabetes Obes Metab
; 19(4): 489-495, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28009472
16.
Euglycaemic glucose clamp: what it can and cannot do, and how to do it.
Diabetes Obes Metab
; 18(10): 962-72, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27324560
17.
Pharmacokinetic and Pharmacodynamic Characteristics of Insulin Icodec After Subcutaneous Administration in the Thigh, Abdomen or Upper Arm in Individuals with Type 2 Diabetes Mellitus.
Clin Drug Investig
; 43(2): 119-127, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36631720
18.
Noninvasive Continuous Glucose Monitoring With a Novel Wearable Dial Resonating Sensor: A Clinical Proof-of-Concept Study.
J Diabetes Sci Technol
; : 19322968231170242, 2023 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37102600
19.
Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging.
Aliment Pharmacol Ther
; 54(9): 1150-1161, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34570916
20.
Dasiglucagon-A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial.
Diabetes Care
; 44(6): 1361-1367, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35239971